Series B funding round for Visen Pharmaceuticals raising $150M in January 2021
Series B funding round for Visen Pharmaceuticals raising $150M in January 2021
| Investor | Firm Type |
|---|
| Partner |
|---|
Sequoia CapitalLEAD | Venture Capital | — |
| Venture Capital | — | |
| Venture Capital | — | |
| Venture Capital | — | |
| Venture Capital | — | |
| Venture Capital | — | |
| Venture Capital | — | |
| Venture Capital | — | |
| Venture Capital | — | |
| Venture Capital | — | |
| Venture Capital | — | |
| Venture Capital | — |
This company has completed 2 funding rounds. Current round is highlighted.
Total Raised
$190M
Top Valuation
-
Visen Pharmaceuticals raised $150M in a Series B round.
The round was announced on 01/01/21.
The round was led by Hongshan Capital Group (Sequoia Capital China).